← Back to Patent Explorer
US4996206A Expired / Lapsed US ⏱️ 0.0 years remaining

N-(pyrrolo[2,3-d]pyrimidin-3-ylacyl)-glutamic acid derivatives

Assignee: Princeton University
•
Filing: 1990-05-24
•
Granted: 1991-02-26
•
Expires: 2010-05-24
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract N-(Acyl)glutamic acid derivatives in which the acyl group is substituted with 4-hydroxypyrrolo[2,3-d]pyrimidin-3-yl group are antineoplastic agents. A typical embodiment is N-[4-(2-{4-hydroxypyrrolo[2,3-d]pyrimidin-3-yl}ethyl)benzoyl]-L-glutamic acid.

Inventors

  • 👤 Edward C. Taylor
  • 👤 Dietmar G. Kuhnt
  • 👤 Chuan Shih
  • 👤 Gerald B. Grindey

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-25 17:34
CPC Classifications
C; C07; C07D; C07D487/00; C07D487/02; C07D487/04

Claims Analysis

Total Claims: 17
Claim 1
Independent Claim 90 words
A compound of the formula: ##STR16## in which: R 1 is -OH or -NH 2 ; R 3 is 1,4-phenylene or 1,3-phenylene unsubstituted or substituted with chloro, fluoro, methyl, methoxy, or trifluoromethyl; thienediyl or furanediyl unsubstituted or substituted with chloro, fluoro, methyl, methoxy, or trifluoromethyl; cyclohexadiyl; and alkanediyl of two to four carbon atoms; R 4 is hydrogen, methyl, or hydroxymethyl; and R 5 is hydrogen or alkyl of 1 to 6 carbon atoms; the configuration about the carbon atom designated * is S; and the pharmaceutically acceptable salts thereof.
Claim 2
Dependent Claim 90 words
A compound of the formula: ##STR16## in which: R 1 is -OH or -NH 2 ; R 3 is 1,4-phenylene or 1,3-phenylene unsubstituted or substituted with chloro, fluoro, methyl, methoxy, or trifluoromethyl; thienediyl or furanediyl unsubstituted or substituted with chloro, fluoro, methyl, methoxy, or trifluoromethyl; cyclohexadiyl; and alkanediyl of two to four carbon atoms; R 4 is hydrogen, methyl, or hydroxymethyl; and R 5 is hydrogen or alkyl of 1 to 6 carbon atoms; the configuration about the carbon atom designated * is S; and the pharmaceutically acceptable salts thereof.
Claim 3
Dependent Claim 20 words
A compound according to claim 1 wherein R 1 is -OH; R 3 is 1,4-phenylene; and R 4 is hydrogen.
Claim 4
Dependent Claim 11 words
A compound according to claim 2 wherein R 5 is hydrogen.
Claim 5
Dependent Claim 11 words
A compound according to claim 2 wherein R 5 is methyl.
Claim 6
Dependent Claim 20 words
A compound according to claim 1 wherein R 1 is -OH; R 3 is 1,4-phenylene, and R 4 is hydroxymethyl.
Claim 7
Dependent Claim 11 words
A compound according to claim 5 wherein R 5 is hydrogen.
Claim 8
Dependent Claim 11 words
A compound according to claim 5 wherein R 5 is methyl.
Claim 9
Dependent Claim 20 words
A compound according to claim 1 wherein R 1 is -OH; R 3 is thienediyl, and R 4 is hydrogen.
Claim 10
Dependent Claim 11 words
A compound according to claim 8 wherein R 5 is hydrogen.
Claim 11
Dependent Claim 11 words
A compound according to claim 8 wherein R 5 is methyl.
Claim 12
Dependent Claim 10 words
The compound according to claim 1 which is N-{4-[2-(4-hydroxypyrrolo[2,3-d]pyrimidin-3-yl)ethyl]benzoyl}-L-glutamic acid.
Claim 13
Dependent Claim 10 words
The compound according to claim 1 which is N-{4-[2-(4-hydroxy-6-methylpyrrolo[2,3-d]pyrimidin-3-yl)ethyl]benzoyl}-L-glutamic acid.
Claim 14
Dependent Claim 32 words
The method of combatting neoplastic growth in a mammal which comprises administering to the mammal in a single or multiple dose regimen an effective amount of a compound according to claim 1.
Claim 15
Dependent Claim 47 words
A pharmaceutical composition for combatting neoplastic growth in a mammal which comprises an amount of a compound according to claim 1 which upon administration to the mammal in a single or multiple dose regimen is effective to combat said growth, in combination with a pharmaceutically acceptable carrier.
Claim 16
Dependent Claim 115 words
A compound of the formula: ##STR17## in which: R 1 is -OH or -NH 2 ; R 2 ' is hydrogen, or a carboxy protecting group; R 3 is 1,4-phenylene or 1,3-phenylene unsubstituted or substituted with chloro, fluoro, methyl, methoxy, or trifluoromethyl, thienediyl or furanediyl unsubstituted or substituted with chloro, fluoro, methyl, methoxy, or trifluoromethyl, cyclohexadiyl, or alkanediyl of two to four carbon atoms; R 4 ' is hydrogen, methyl, hydroxymethyl, or hydroxymethyl substituted with a hydroxy protecting group; and R 5 40 is hydrogen or alkyl of 1 to 6 carbon atoms, at least one of R 2 ' and R 4 ', being a carboxy protecting group or a hydroxy protecting group, respectively.
Claim 17
Dependent Claim 115 words
A compound of the formula: ##STR17## in which: R 1 is -OH or -NH 2 ; R 2 ' is hydrogen, or a carboxy protecting group; R 3 is 1,4-phenylene or 1,3-phenylene unsubstituted or substituted with chloro, fluoro, methyl, methoxy, or trifluoromethyl, thienediyl or furanediyl unsubstituted or substituted with chloro, fluoro, methyl, methoxy, or trifluoromethyl, cyclohexadiyl, or alkanediyl of two to four carbon atoms; R 4 ' is hydrogen, methyl, hydroxymethyl, or hydroxymethyl substituted with a hydroxy protecting group; and R 5 40 is hydrogen or alkyl of 1 to 6 carbon atoms, at least one of R 2 ' and R 4 ', being a carboxy protecting group or a hydroxy protecting group, respectively.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1994-02-25 1994-08-27 1995-02-26 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1998-02-25 1998-08-27 1999-02-26 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2002-02-25 2002-08-27 2003-02-26 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag